REPL Insider Holders & Insider Ownership

List of insiders holdings for Replimune Group Inc.:

Shares directly owned by the insider.
Shares indirectly owned by the insider.
Total shares owned by the insider (sum of shares directly and indirectly owned).
Total market value if available.
Shares are not adjusted for stock split.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Insider Holder Name	Report Date Time	Shares Owned Directly Indirectly	Total Shares Owned	Filing
Forbion Capital Fund III Cooperatief U.A. 10% Owner	2024-11-14 07:00:55	5,115,121 0	5,115,121	Form 13G
Redmile Group LLC Green Jeremy 10% Owner	2024-02-14 16:26:22	4,604,483 0	4,604,483	Form 13G
Omega Fund IV L.P. Omega Fund IV GP L.P. Omega Fund IV G.P. Manager Ltd. Stampacchia Otello Lim Richard J. Paster Anne-Mari 10% Owner	2024-11-14 08:35:56	2,709,991 0	2,709,991	Form 13G
Omega Fund IV L.P. Omega Fund IV GP L.P. Omega Fund IV G.P. Manager Ltd. Stampacchia Otello Paster Anne-Mari Director 10% Owner	2024-11-14 08:35:56	2,709,991 0	2,709,991	Form 13G
Omega Fund IV L.P. Omega Fund IV GP L.P. Omega Fund IV G.P. Manager Ltd. Stampacchia Otello 10% Owner	2024-11-14 08:35:56	2,709,991 0	2,709,991	Form 13G
Coffin Robert Director	2024-05-20 20:02:44	1,821,872 0	1,821,872	Form 4
Atlas Venture Fund X L.P. Atlas Venture Associates X LLC ATLAS VENTURE ASSOCIATES X L.P. 10% Owner	2022-12-06 17:00:05	1,498,635 0	1,498,635	Form 13D
Atlas Venture Fund X L.P. 10% Owner	2022-12-06 17:00:05	1,498,635 0	1,498,635	Form 13D
Astley-Sparke Philip Executive Chairman	2024-08-30 20:00:06	1,437,350 0	1,437,350	Form 4
Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC See Remarks	2019-11-20 17:49:10	0 1,100,000	1,100,000	Form 3
Love Colin Chief Operating Officer	2024-05-20 20:05:37	777,345 0	777,345	Form 4
Esposito Pamela Chief Business Officer	2023-09-13 21:02:56	435,802 0	435,802	Form 4
Patel Sushil Chief Executive Officer	2024-05-20 20:01:55	212,014 0	212,014	Form 4
Kaufman Howard Chief Medical Officer	2019-12-19 16:02:37	149,202 0	149,202	Form 4
Lewis Tanya Chief Dev. Op. Officer	2023-06-15 21:01:04	135,293 0	135,293	Form 4
Franchi Jean M. Chief Financial Officer	2023-05-18 20:32:47	128,748 0	128,748	Form 4
Xynos Konstantinos Chief Medical Officer	2024-11-20 21:31:54	109,885 0	109,885	Form 4
Hill Emily Luisa Chief Financial Officer	2024-08-19 20:00:04	101,057 0	101,057	Form 4
Sarchi Christopher Chief Commercial Officer	2024-11-20 21:30:24	87,045 0	87,045	Form 4
GORGOL STEPHEN A Chief Accounting Officer	2020-04-02 16:35:33	66,050 0	66,050	Form 4
Balachandran Madhavan Director	2024-09-05 20:10:13	64,000 0	64,000	Form 4
Pirzkall Andrea Chief Medical Officer	2021-04-05 20:19:45	52,250 0	52,250	Form 4
Schwendenman Andrew Chief Accounting Officer	2024-05-20 20:06:11	38,238 0	38,238	Form 4
Pucci Paolo Director	2024-04-03 20:02:50	32,000 0	32,000	Form 4
Peeples-Dyer Veleka Director	2024-04-03 20:04:25	32,000 0	32,000	Form 4
Dhingra Kapil Director	2024-04-03 20:01:38	32,000 0	32,000	Form 4
SLATTERY JOSEPH P Director	2024-04-03 20:01:00	32,000 0	32,000	Form 4
Weinand Dieter Director	2024-04-03 20:00:56	32,000 0	32,000	Form 4
Oliger Christy J. Director	2024-04-03 20:00:47	32,000 0	32,000	Form 4
Levitsky Hyam Director	2024-04-03 20:00:27	32,000 0	32,000	Form 4
Slootweg Hugo Alexander Director	2023-04-04 20:04:24	25,200 0	25,200	Form 4
Rhodes Jason P Director	2022-04-05 16:13:35	16,500 0	16,500	Form 4
Bain Capital Life Sciences Investors LLC Bain Capital Life Sciences Partners LP Bain Capital Life Sciences Fund L.P. BCIP Life Sciences Associates LP Schwartz Jeffrey Lawrence Koppel Adam 10% Owner	2021-02-16 15:15:05	0 0	0	Form 13G

Insider Holders & Insider Ownership - Replimune Group Inc. (REPL)